Market Capitalization

With a new U.S. patent, Quoin Pharmaceuticals reinforces its strategy for QRX003, a potential first-ever treatment for devastating Netherton Syndrome.

An investigation into nursing home giant Ensign reveals a troubling intersection of high finance, regulatory loopholes, and the vulnerable lives in its care.

Live Oak Bank's hire of a top accounting chief isn't just a personnel move. It signals a new age of accountability for digital banks, where growth meets governance.

FibroBiologics secures $3M with a path to $9M, fueling its promising cell therapy pipeline. But is this a strategic masterstroke or a necessary risk?

Hub Group's multi-year accounting scandal reveals deep-seated control failures, sparking a class action lawsuit and wiping out nearly a billion in market value.

Following BHP-backed research that reframed a region's potential, New Frontier Minerals accelerates its high-stakes search for the metals powering our future.

With its new mycelium-based steak filet hitting grocery stores, Beyond Meat is making a high-stakes play to redefine plant-based protein and turn its fortunes around.

InTest Corp's inclusion in the Russell 2000/3000 is more than a ticker change. It's a validation of a growth strategy in critical tech sectors.

Struggling disinfection firm TOMI Environmental merges with Carbonium Core, betting its future on a domestic supply chain for the AI-fueled nuclear renaissance.

The community-owned retailer gains institutional visibility with its Russell 3000 inclusion, but staggering losses and a volatile past paint a complex picture.

LightPath Technologies' Russell 3000 inclusion is no accident. It's a story of operational innovation and vertical integration in a critical sector.

Almonty Industries' inclusion in the Russell 1000 is more than a stock market milestone. It validates a strategy built at the nexus of profit and geopolitics.

MDJM Ltd. appoints a top sinologist for its ambitious Fernie Castle project, a high-stakes bet that academic rigor can build a bridge between Eastern philosophy and Western commerce.

Activist investor SilverCape issues a stark ultimatum to PetMed Express, cutting its takeover bid from $4 to $3, blaming board inaction for value destruction.

Relmada Therapeutics joins the Russell 2000, a key validation that opens doors to new capital. But can its high-stakes pipeline deliver on this promise?

Farmmi Inc.'s $3M offering sent its stock plummeting 69%. Is this a desperate move for survival or a strategic play to fund its ambitious U.S. expansion?

Ring Energy's entry into the Russell 3000 is more than a milestone; it's a testament to strategic discipline. What does this reveal about value creation?

A small Shanghai tech firm just raised $1.5M to fund its AI pivot. Is this a savvy move for survival or a drop in the ocean of a global tech arms race?

Orion S.A.'s minor dividend hike projects stability, but a look at recent financials and market trends reveals a more complex picture for the carbon black giant.

As investors bet on AI creating 'God,' one expert warns of a bubble. With key earnings reports looming, are today's massive valuations built on faith or fundamentals?